使用心率数据预测1型糖尿病患者的葡萄糖值
Raffaele Giancotti1, Pietro Bosoni2, Patrizia Vizza1
1Department of Surgical and Medical Sciences, Magna Graecia University of Catanzaro, Italy.
Computer methods and programs in biomedicine
|September 27, 2024
概括
这项研究引入了一个新的框架,使用Gated Recurrent Unit (GRU) 模型来改善1型糖尿病患者 (T1DM) 的葡萄糖水平预测. 该模型通过结合心率 (HR) 和间歇性葡萄糖 (IG) 数据来提高持续葡萄糖监测 (CGM) 的准确性,降低低血糖的风险.
科学领域:
- 生物医学工程 生物医学工程
- 医疗保健中的人工智能
- 代谢性疾病管理
背景情况:
- 1型糖尿病 (T1DM) 需要持续的葡萄糖监测和胰岛素管理.
- 目前的连续葡萄糖监测 (CGM) 系统面临的局限性包括时间延迟和预测准确性.
- 准确的葡萄糖预测对于预防低血糖等并发症至关重要.
研究的目的:
- 开发和验证一种新的框架,以提高T1DM患者的葡萄糖水平预测.
- 提高短期和长期葡萄糖预测的精度和可靠性.
- 通过整合生理数据来优化CGM系统,以便更好地管理糖尿病.
主要方法:
- 为了预测葡萄糖值,采用了门式循环单位 (GRU) 模型.
- 该框架利用心率 (HR) 和间歇性葡萄糖 (IG) 数据进行预测.
- 在俄俄T1DM数据集和两个额外的T1DM数据集上接受培训和验证.
主要成果:
- 基于GRU的框架在预测间歇性葡萄糖 (IG) 值方面表现出卓越的准确性.
- 在各种预测视野中实现了改进的根平均平方误差 (RMSE) 和平均绝对误差 (MAE).
- 开源框架可用于进一步的研究和开发.
结论:
- 拟议的框架为T1DM管理的葡萄糖水平预测提供了显著的进步.
- 将HR和IG数据与GRU模型集成,可以提高预测准确度并减轻低血糖风险.
- 这种方法有望优化自动化胰岛素输送系统和患者的治疗结果.
相关概念视频
Pulse rhythm
769
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
769
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Hypoglycemia and Glucagon
206
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
206
Glucose Homeostasis: Regulation of Blood Glucose
1.5K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
1.5K
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Insulin: Dosing Regimen and Adverse Effects
155
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
155


